SARS-CoV-2

From WikiMD's WELLNESSPEDIA

SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) is a strain of coronavirus that was first identified in December 2019 in the city of Wuhan, Hubei province, China. It is the causative agent of the ongoing COVID-19 pandemic, which has had significant global health and economic impacts.

Origin and Naming[edit]

SARS-CoV-2 is part of the broader Coronaviridae family of viruses, which also includes the viruses responsible for SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome). The virus was initially referred to as the "2019 novel coronavirus" or "2019-nCoV" before being officially named SARS-CoV-2 by the International Committee on Taxonomy of Viruses (ICTV) in February 2020.

Structure and Genome[edit]

SARS-CoV-2 is an enveloped, positive-sense, single-stranded RNA virus. Its genome is approximately 30,000 bases in length, making it one of the largest RNA viruses. The virus has a distinctive "crown" of spike proteins on its surface, which it uses to bind to and enter host cells.

Transmission and Symptoms[edit]

SARS-CoV-2 is primarily transmitted between people through respiratory droplets, although other modes of transmission, such as contact with contaminated surfaces, are also possible. The virus causes a range of symptoms, from mild symptoms such as fever and cough, to severe symptoms such as pneumonia and acute respiratory distress syndrome (ARDS). Some individuals may be asymptomatic carriers of the virus.

Prevention and Treatment[edit]

Prevention measures for SARS-CoV-2 include social distancing, wearing masks, and hand hygiene. As of now, several vaccines have been developed and are being distributed globally. Treatment primarily involves supportive care, although certain antiviral drugs have shown some efficacy.

Impact[edit]

The COVID-19 pandemic caused by SARS-CoV-2 has had significant global impacts, affecting health systems, economies, and daily life. Efforts to control the spread of the virus have included widespread testing, contact tracing, and quarantine measures.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.